Wikidata

(Q113915010)

English

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

clinical trial

In more languages

Statements

title
A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects With Early Alzheimer´s Disease (EVOKE Plus) (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Serbia
0 references
Slovakia
0 references
Slovenia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
18 May 2021
0 references
end time
9 August 2024
0 references
number of participants
1,840
0 references
minimum age
55 year
0 references
maximum age
85 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113915010&oldid=2148827771"